Author： Rouquet Thaïs Bonnet Marion S Pierre Clément Dallaporta Michel Troadec Jean-Denis Roux Julien Bariohay Bruno
Publisher： Future Science
ISSN： 2046-8954
Source： Pharmaceutical Patent Analyst, Vol.2, Iss.3, 2013-05, pp. : 399-427
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Dapagliflozin for the treatment of type 2 diabetes
By Abdul-Ghani Muhammad A DeFronzo Ralph A
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. :
Access to resources
Recommend
Linagliptin: In Type 2 Diabetes Mellitus
Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. :
Metformin ++ saxagliptin for type 2 diabetes
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 1, 2012-01 ,pp. :
Linagliptin for the treatment of type 2 diabetes
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 17, 2011-12 ,pp. :